By Quian Vencel Galut

PHOTO: Tech Times

The full authorization of Pfizer-BioNTech COVID-19 vaccine in the United States will fast-track the process of Philippine regulators of allowing the jab for commercial use in the country, said Malacañang.

Presidential spokesperson Harry Roque explained that the process will be faster once the full approval by the U.S. FDA for Pfizer-BioNTech applied in the Philippines.

In a press briefing, Roque said that while the commercial use approval of the Philippine FDA is still needed, the Philippine FDA’s policy will be hastened due to quickly approving commercial use of vaccines and medicines that are already secured for approval by a “stringent” regulator like the U.S. FDA.

“Bagamat kinakailangan pa rin bigyan ng commercial use approval ng Philippine FDA ang Pfizer, ito po ay mapapabilis dahil meron po tayong polisiya na ang Philippine FDA ay mas mabilis na naaprubahan for commercial use ang mga bakuna’t gamot na meron nang approval sa mga stringent na FDAs gaya po ng Estados Unidos,” Roque said.

“Konting panahon na lang po at mabibili na sa ating mga botika ang Pfizer kung ito po ang inyong preferred brand,” he added.

Having emergency use authorization (EUA) on Pfizer’s COVID-19 vaccines, it is clear that only the national government can only buy the said product with an EUA and cannot be sold commercially in the Philippines.